Korea’s Naver, Celltrion, Samsung BioLogics on Fortune’s ‘Future 50’ list
Oct 19, 2018
South Korean internet giant Naver and the country’s top biopharma companies Celltrion and Samsung BioLogics have been listed on Fortune’s Future 50, which ranks global companies with the best prospects for long-term growth. The global business magazine on Friday announced the Future 50 list, compiled annually in partnership with the Boston Consulting Group. Naver, which operates Korea’s dominant portal website, ranked sixth. Celltrion, a developer of biosimilar drugs, ranked 17th, while contract